119 related articles for article (PubMed ID: 3693763)
1. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.
Anderson MC; Baer H; Frazier DJ; Quinnan GV
J Allergy Clin Immunol; 1987 Dec; 80(6):861-8. PubMed ID: 3693763
[TBL] [Abstract][Full Text] [Related]
2. IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine.
Swanson MC; Rosanoff E; Gurwith M; Deitch M; Schnurrenberger P; Reed CE
J Infect Dis; 1987 May; 155(5):909-13. PubMed ID: 3559291
[TBL] [Abstract][Full Text] [Related]
3. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations.
Fishbein DB; Dreesen DW; Holmes DF; Pacer RE; Ley AB; Yager PA; Sumner JW; Reid-Sanden FL; Sanderlin DW; Tong TC
Vaccine; 1989 Oct; 7(5):437-42. PubMed ID: 2815979
[TBL] [Abstract][Full Text] [Related]
4. Sensitization induced in guinea pigs with beta-propiolactone-treated serum albumin: experimental evidence for the cause of allergic reactions in humans receiving human diploid cell rabies vaccines.
Levenbook IS; Merritt BA; Fitzgerald EA; Elisberg BL
Int Arch Allergy Appl Immunol; 1986; 80(1):110-1. PubMed ID: 3957443
[TBL] [Abstract][Full Text] [Related]
5. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
[TBL] [Abstract][Full Text] [Related]
6. Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination.
Bernard KW; Mallonee J; Wright JC; Reid FL; Makintubee S; Parker RA; Dwyer DM; Winkler WG
JAMA; 1987 Feb; 257(8):1059-63. PubMed ID: 3806894
[TBL] [Abstract][Full Text] [Related]
7. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization.
Dreesen DW; Fishbein DB; Kemp DT; Brown J
Vaccine; 1989 Oct; 7(5):397-400. PubMed ID: 2815976
[TBL] [Abstract][Full Text] [Related]
8. A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children.
Sabchareon A; Lang J; Attanath P; Sirivichayakul C; Pengsaa K; Le Mener V; Chantavanich P; Prarinyanuphab V; Pojjaroen-Anant C; Nimnual S; Wood SC; Riffard P
Clin Infect Dis; 1999 Jul; 29(1):141-9. PubMed ID: 10433577
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
Arora A; Moeller L; Froeschle J
J Travel Med; 2004; 11(4):195-9. PubMed ID: 15541220
[TBL] [Abstract][Full Text] [Related]
10. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
[TBL] [Abstract][Full Text] [Related]
11. Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine.
Dreesen DW; Bernard KW; Parker RA; Deutsch AJ; Brown J
Vaccine; 1986 Mar; 4(1):45-9. PubMed ID: 2938356
[TBL] [Abstract][Full Text] [Related]
12. [Properties and potency of a rabies vaccine produced on the brain matter of young goats and inactivated by beta-propiolactone].
Mansour AB; Abrous M
Dev Biol Stand; 1978; 41():217-24. PubMed ID: 753652
[TBL] [Abstract][Full Text] [Related]
13. Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses.
Bernard KW; Roberts MA; Sumner J; Winkler WG; Mallonee J; Baer GM; Chaney R
JAMA; 1982 Feb; 247(8):1138-42. PubMed ID: 7057603
[TBL] [Abstract][Full Text] [Related]
14. Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose.
Rodrigues FM; Mandke VB; Roumiantzeff M; Rao CV; Mehta JM; Pavri KM; Poonawalla C
Epidemiol Infect; 1987 Aug; 99(1):91-5. PubMed ID: 3609177
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
[TBL] [Abstract][Full Text] [Related]
16. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine.
Fishbein DB; Bernard KW; Miller KD; Van der Vlugt T; Gains CE; Bell JT; Sumner JW; Reid FL; Parker RA; Horman JT
Am J Trop Med Hyg; 1986 May; 35(3):663-70. PubMed ID: 3706630
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study.
Fishbein DB; Yenne KM; Dreesen DW; Teplis CF; Mehta N; Briggs DJ
Vaccine; 1993 Nov; 11(14):1390-4. PubMed ID: 8310759
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
Sasaki Y; Yoshino N; Sato S; Muraki Y
J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
[TBL] [Abstract][Full Text] [Related]
20. Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.
Morgeaux S; Tordo N; Gontier C; Perrin P
Vaccine; 1993; 11(1):82-90. PubMed ID: 8427040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
